B-type natriuretic peptide trumps other prognostic markers in patients assessed for coronary disease

Abstract Background Risk prediction for patients with suspected coronary artery disease is complex due to the common occurrence of prior cardiovascular disease and extensive risk modification in primary care. Numerous markers have the potential to predict prognosis and guide management, but we curre...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dipak Kotecha, Marcus D. Flather, Dan Atar, Peter Collins, John Pepper, Elizabeth Jenkins, Christopher M. Reid, David Eccleston, on behalf of the Alternative Risk Markers in Coronary Artery Disease (ARM-CAD) Study
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2019-04-01
Saila:BMC Medicine
Gaiak:
Risk
Mortality
Coronary artery disease
Coronary angiography
B-type natriuretic peptide
Sarrera elektronikoa:http://link.springer.com/article/10.1186/s12916-019-1306-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak